Using Libre 3 Plus or Dexcom G7 Continuous Glucose Monitors for Managing Diabetes After Hospital Discharge

What this Trial Is About

This research aims to improve how patients with Type 1 or Type 2 diabetes and hyperglycemia manage their blood sugar after leaving the hospital. It focuses on increasing patient awareness and satisfaction with continuous glucose monitoring systems during the transition from inpatient care to outpatient settings. The study is interventional and compares two different continuous glucose monitoring devices to understand their impact on diabetes care. Participants will be randomly assigned to start using either the Libre 3 Plus or the Dexcom G7 continuous glucose monitor. Both devices connect with smartphone applications to help patients track their glucose levels. The study begins during hospitalization and continues with follow-up telephone visits 2 to 3 weeks after discharge to assess patient experiences and glucose control. During the study, participants will complete questionnaires about their satisfaction with the glucose monitors and the quality of their diabetes care, as well as their familiarity with continuous glucose monitoring. Researchers will also track changes in hemoglobin A1C and glucose management indicators, along with any hospital readmissions related to blood sugar control within 30 days. The total participation involves enrollment during hospitalization and follow-up shortly after discharge.

Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge